Peter Richardson

Peter Richardson

Company: BenevolentAI

Job title: Vice President Pharmacology

Seminars:

Case Study – The Powerful Impact of Artificial Intelligence on SARS-CoV-2 Drug Repurposing Efforts 9:45 am

• Why AI and machine learning models are necessary to repurpose drugs in response to Covid-19 • Leveraging AI technology is providing promising repurposing results • Drug repurposing has an exciting future, with further successful AI models for repurposing to comeRead more

day: Day One

Panel Discussion – Repurposing Prominence During Covid-19 9:00 am

Drug repurposing has shone during the pandemic, but will the lessons learned translate into a more organized response for future pandemics?Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.